Promis Neurosciences Inc

Biotech Stocks Healthcare Stocks

$10.65

-0.62 (-5.50%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +116.0% upside

Low Target $15.62

Average Target $23.00

High Target $28.09

Current Price $10.65

Current
$10.65

Target
$23.00

$15.62 $23.00 avg $28.09

Scenario Analysis

Bear Case

$15.62

46.7%

Low target

Base Case

$23.00

+116.0%

Avg target

Bull Case

$28.09

+163.8%

High target

Risk/Reward

3.5x

Highly favorable

Price in Context

52-Week High

$27.40

-61.1% from high

52-Week Low

$6.27

+69.9% from low

Target vs 52W High

$23.00

-16.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%